In breast cancer, lncRNAPVT1 has been proven to play an oncogenic function by protecting cMYC protein, which plays emerging roles in cancer stemness and resistance to chemotherapy from phosphorylation-mediated degradation [38,39]. Here, MYC is linked to cancer.